Skip to main content
Log in

The genetic basis of Ro and La antibody formation in systemic lupus erythematosus

Results of a multicenter study

  • Originals
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

Antibodies against Ro and La, including recombinant La and recombinant 60 kD-Ro, were determined by counter immunoelectrophoresis and ELISA in over 300 central European systemic lupus erythematosus (SLE) patients. The presence of both Ro and La antibodies was strongly associated with the MHC haplotype B8-C4AQ0-DR3-DQ2, the association being stronges for DR3. After exclusion of all B8-DR3 positive patients only DR3 positive patients still showed an increased incidence of Ro and La antibodies, suggesting DR3 as the primary association factor. High titers of La antibody, but not of 60 kD-Ro antibody, were also significantly associated with the presence of DR3. Other DR and DQ antigens or heterozygous DQ combinations were not significantly associated with Ro and La antibodies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shen HH, Winchester RJ (1986) Susceptibility genetics of systemic lupus erythematosus. Springer Semin Immunopathol 9:143–159

    Google Scholar 

  2. Hartung K, Fontana A, Klar M, Krippner H, Jörgens K, Lang B, Peter HH, Pichler WJ, Schendel D, Robin-Winn M, Deicher H (1989) Association of class I, II, and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study. Rheumatol Int 9:13–18

    Google Scholar 

  3. Rynes RI (1982) Inherited complement deficiency states and SLE. Systemic lupus erythematosus. Clin Rheum Dis 8:29–47

    Google Scholar 

  4. Hochberg MC (1989) Genetics and epidemiology of SLE. Proceedings of the 2nd International Conference on SLE. Singapore, pp 8–13

  5. Fronek Z, Timmerman LA, Alper CA, Hahn BH, Kalunian K, Peterlin BM, McDevitt HO (1990) Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum 33:1542–1553

    Google Scholar 

  6. Warlow RS (1986) Subsets of autoantibodies to extractable nuclear antigens (ENA) as assayed by ELISA correlate with specific clinical abnormalities in SLE. Scand J Rheumatol 15:57–67

    Google Scholar 

  7. Tsokos GC, Pillemer ST, Klippel JH (1987) Rheumatic disease syndromes associated with antibodies to the Ro (SS-A) ribonuclear protein. Semin Arthritis Rheum 16:237–244

    Google Scholar 

  8. Smolen JS, Klippel JH, Penner E, Reichlin M, Steinberg AD, Chused TM, Scherak O, Graninger W, Hartter E, Zielinski CC, Wolf A, Davey RJ, Mann DL, Mayr WR (1987) HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Ann Rheum Dis 46:457–462

    Google Scholar 

  9. Bell DA, Maddison PJ (1980) Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 23:1268–1273

    Google Scholar 

  10. Ahearn JM, Provost TT, Dorsch CA, Stevens MB, Bias WB, Arnett FC (1982) Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum 25:1031–1040

    Google Scholar 

  11. Schur PH, Meyer I, Garovoy M, Carpenter CB (1982) Associations between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological considerations. Clin Immunol Immunopathol 24:263–275

    Google Scholar 

  12. Griffing WL, Moore S, Luthra HS, McKenna CH, Fathman CG (1980) Associations of antibodies to native DNA with HLA-DRw3: a possible major histocompatibility-linked human immune response gene. J Exp Med 152:319S-325S

    Google Scholar 

  13. Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT, Stevens MB (1985) Systemic lupus erythematosus: A review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 64:285–295

    Google Scholar 

  14. Alvarellos A, Ahearn JM, Provost TT, Dorsch CA, Stevens MR, Bias WB, Arnett FC (1983) Relationship of HLA-DR and MT antigens to autoantibody expression in systemic lupus erythematosus. Arthritis Rheum 26:1533–1535

    Google Scholar 

  15. Genth E, Mierau R, Genetzky P, Mühlen CA von, Kaufmann S, Wilmowsky H von, Meurer M, Krieg T, Pollmann HJ, Hartl PW (1990) Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum 33:657–665

    Google Scholar 

  16. Savi M, Ferracioli GF, Neri TM, Zanelli P, Dall'Aglio PP, Tincaini A, Balestrieri G, Carella G, Cattaneo R (1988) HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum 31:1568–1570

    Google Scholar 

  17. Tincani A, Carella G, Balestrieri G, Cattaneo R (1986) Antiphospholipid antibodies and HLA. Clin Exp Rheumatol 4:294–295

    Google Scholar 

  18. Hartung K, Coldewey R, Corvetta A, Deicher H, Kalden JR, Krapf F, Lang B, Lakomek HJ, Liedvogel B, Peter HH et al (1991) MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus. Autoimmunity (in press)

  19. Reichlin M (1987) Antibodies of cytoplasmic antigens. In: Lahita R (ed) Systemic lupus erythematosus. Wiley, New York, pp 257–270

    Google Scholar 

  20. Petri M, Watson R, Hochberg MC (1989) Anti-Ro antibodies and neonatal lupus. Rheum Dis Clin North Am 15:335–359

    Google Scholar 

  21. Maddison PJ, Provost TT, Reichlin M (1981) Serological findings in patients with “ANA-negative” systemic lupus erythematosus. Medicine 60:87–94

    Google Scholar 

  22. Vandersteen PR, Provost TT, Jordon RE, McDuffie FC (1982) C2 deficient systemic lupus erythematosus. Its association with anti-Ro (SSA) antibodies. Arch Dermatol 118:584–587

    Google Scholar 

  23. Logar D, Kveder T, Rozman B, Dobovisek J (1990) Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 49:627–629

    Google Scholar 

  24. Sontheimer RD, Maddison PJ, Reichlin M et al (1982) Serological and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 97:664–671

    Google Scholar 

  25. Purcell SM, Lieu TS, Davis BM et al (1985) Relationship between circulating anti Ro/SSA antibody levels and skin disease activity in subacute cutaneous lupus erythematosus (SCLE). Arthritis Rheum 28 [Suppl]:S76

  26. Watson RM, Lane AT, Barnett NK et al (1984) Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine 63:362–378

    Google Scholar 

  27. Meyer O, Hauptmann G, Tappeiner G, Ochs HD, Mascart-Lemone F (1985) Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies. Clin Exp Immunol 62:678–684

    Google Scholar 

  28. Frank MB, McArthur R, Harley JB, Fujisaku A (1990) Anti-Ro (SSA) autoantibodies are associated with T cell receptor β-genes in systemic lupus erythematosus patients. J Clin Invest 85:33–39

    Google Scholar 

  29. Whittingham S, Propert DN, Mackay IR (1984) A strong association between the antinuclear antibody anti-La (SS-B) and the kappa chain allotype Km(1). Immunogenetics 19:295–299

    Google Scholar 

  30. Specker CH, Lakomek HJ, Kuntz BME, Bremer G, Goerz G, Krüskemper HL (1987) Signifikante Assoziation des HLA-B8 zum systemischen Lupus erythematodes und zu bestimmten serologischen Markern. Dtsch Med Wochenschr 112:577–580

    Google Scholar 

  31. Wilson RW, Provost TT, Bias WB, Alexander EL, Edlow DW, Hochberg MC, Stevens MB, Arnett FC (1984) Sjögren's syndrome: Influence of multiple HLA-D region alloantigens on clinical and serologic expression. Arthritis Rheum 27:1245–1253

    Google Scholar 

  32. Provost TT, Talal N, Bias W, Harley JB, Reichlin M, Alexander EL (1988) Ro (SS-A) positive Sjögren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes. J Invest Dermatol 91:369–371

    Google Scholar 

  33. Alexander EL, McNicholl J, Watson RM, Bias W, Reichlin M, Provost TT (1989) The immunogenetic relationship between anti-Ro (SS-A)/La (SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome. J Invest Dermatol 93(6):751–756

    Google Scholar 

  34. Hamilton RG, Harley JB, Bias WB, Roebber M, Reichlin M, Hochberg MC, Arnett FC (1988) Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus: correlation of HLA-Dr/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 31:496–505

    Google Scholar 

  35. Arnett FC, Hamilton RG, Reville JD, Bias WB, Harley JB, Reichlin M (1989) Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum 32:413–419

    Google Scholar 

  36. Fujisaku A, Frank MB, Neas B, Reichlin M, Harley JB (1990) HLA-DQ gene complementation and other histocompatibility relationships in man with the anti-Ro/SSA autoantibody response of systemic lupus erythematosus. J Clin Invest 86:606–611

    Google Scholar 

  37. Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT (1986) Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 232:1145–1147

    Google Scholar 

  38. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1278

    Google Scholar 

  39. Terasaki PI (1965) Microdroplet assay for human blood lymphotoxins. In Histocompatibility testing. National Academy of Science, Washington, DC, p 171

    Google Scholar 

  40. Baur MP, Neugebauer M, Deppe H, Sigmund M, Luton T, Mayr WR, Albert ED (1984) Population analysis on the basis of deduced haplotypes from random families. In: Histocompatibility testing 1984. Springer, Berlin Heidelberg New York

    Google Scholar 

  41. Schendel DJ, O'Neill GJ, Wank R (1984) MHC-linked class III genes. Analysis of C4 gene frequencies, complotypes and association with distinct HLA haplotypes in German Caucasians. Immunogenetics 20:23–31

    Google Scholar 

  42. O'Neill GJ (1984) C4 polymorphism: use of monoclonal antibody to distinguish C4A and C4B locus products. Vox Sang 47:362–365

    Google Scholar 

  43. Essen A (1978) A simple method for quantitative, semiquantitative and qualitative assay of protein. Anal Biochem 89:264–268

    Google Scholar 

  44. Mauff G, Alper CA, Awdeh Z, Batchelor JR, Bertrams J, Bruun-Petersen G, Dawkins RL, Démant P, Edwards J, Grosse-Wilde H, Hauptmann G, Kouda P, Lamm L, Mollenhauer E, Nerl C, Olaisen R, O'Neill G, Rittner C, Roos MH, Skanes V, Teisberg P, Wells L (1983) Statement on the nomenclature of human C4 allotypes. Immunobiology 164:184–191

    Google Scholar 

  45. Kurata N, Tan EM (1976) Identification of antibodies to nuclear acidic antigens by counter immunoelectrophoresis. Arthritis Rheum 19:574–581

    Google Scholar 

  46. Deutscher SL, Harley JB, Keene JD (1988) Molecular analysis of the 60-KD human Ro ribonucleoprotein. Proc Natl Acad Sci USA 85:9479–9483

    Google Scholar 

  47. Chambers JC, Kenan D, Martin BJ, Keene JD (1988) Genomic structure and amino acid sequence domains of the human La autoantigen. J Biol Chem 263:18043–18051

    Google Scholar 

  48. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. In: Nolan C (ed). A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York, pp 17.1–17.44

    Google Scholar 

  49. Strebel K, Beck E, Strohmaier K, Schaller H (1986) Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. J Virol 57:983–991

    Google Scholar 

  50. Alper CA, Awdeh ZL, Yunis EJ (1989) Complotypes and extended haplotypes in laboratory medicine. Complement Inflamm 6:8–18

    Google Scholar 

  51. Hartung K, Baur M, Lakomek HJ, Kalden JR, Peter HH, Schneider P, Schendel D, Lange GG de, Deicher H (1991) Genetische Grundlagen des systemischen Lupus Erythematodes-ergebnisse der Deutschen Multizentrischen SLE-Studie. Z Rheumatol 50(4):274 (abstr)

    Google Scholar 

  52. Hardin JA (1986) The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 29:457–460

    Google Scholar 

  53. Itoh Y, Rader MD, Reichlin M (1990) Heterogeneity of the Ro/SSA antigen and autoanti-Ro/SSA response: evidence of the four antigenically distinct forms. Clin Exp Immunol 81:45–51

    Google Scholar 

  54. Ben-Chetrit E, Fox RI, Tan EM (1990) Dissociation of immune responses to the SS-A (Ro) 52-kD and 60-kD polypeptides in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum 33:349–355

    Google Scholar 

  55. Ambinder JM, Chiorazzia N, Gibofski A, Fotino M, Kunkel HG (1982) Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type. Clin Immunol Immunopathol 23:269–274

    Google Scholar 

  56. Tiwari JL, Terasaki PU (1985) HLA and disease associations. Springer, Berlin Heidelberg New York, pp 431–444

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Additional information

E. Albert, M. Baur, A. Corvetta, J. Frey, J. R. Kalden, G. G. de Lange, H. H. Peter, K. Pirner, R. Röther, P. Schneider, S. Seuchter, P. Späth, C. Specker, W. Stangel, S. Stannat-Kießling

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hartung, K., Coldewey, R., Ehrfeld, H. et al. The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Rheumatol Int 11, 243–249 (1992). https://doi.org/10.1007/BF00301501

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00301501

Key words

Navigation